UNSPSC 51287010: Dicloralurea

This classification denotes an industrial aid with the molecular formula C5H6Cl6N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9J3ZB93FIE, chemically known as 1,3-bis(2,2,2-trichloro-1-hydroxyethyl)urea but more generally known as dicloralurea, which bears US NIH Compound Identifier 8313. European Medicines Agency schedules Dicloralurea in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07098MIG.

The term DICLORALUREA is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 28, No. 10 1974, List 14). DICLORALUREA is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: CLC(CL)(CL)C(O)NC(=O)NC(O)C(CL)(CL)CL.

UNSPSC 51287010 Dicloralurea, a Commodity-level code, shows minimal alignment with recent state and local procurement activity. The code nominally covers a specific chemical compound used in industrial and agricultural applications, yet recent opportunities tagged under it address naloxone procurement, pharmacy benefit management systems, emergency medical supplies, and pharmaceutical distribution — none of which involve dicloralurea as a procurement object. The mismatch suggests either miscoding in source systems or that the code sees little genuine demand in state and local markets, making it difficult to characterize what governments actually buy under this designation.

The available opportunities reflect purchasing across health and human services agencies rather than procurement directly tied to the chemical's industrial use. Seminole County, Florida issued an IFB (IFB60459723LAS, due July 26, 2023) for naloxone and drug deactivation systems; the Texas Health and Human Services Commission posted an RFI (HHS0017013, due April 3, 2026) on direct-to-manufacturer prescription programs; the City of Tampa released an ITB (26P00145, due March 13, 2026) for medical and first aid supplies to the Fire Department with an estimated contract value of $700,000.00 and SLBE set-asides; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP (S1070000015802, due March 26, 2026) for generic pharmaceuticals and OTC products across participating state and local facilities. These solicitations span Florida, Texas, Minnesota, and Oregon, but none substantively engage the commodity as named. Bidders evaluating this code should verify internal procurement system coding and consider whether the code designation reflects a data-quality issue rather than genuine market demand.